fda approved weight loss glp-1 Wegovy Pill Wins Approval as First Oral Treatment for Obesity and Retatrutide Weight Loss Results:Trial Data

TEXT OR CALL (303) 790-8446 TO SCHEDULE AN APPOINTMENT Free consultations are provided via text or over the phone only

Rybelsus now also carries proven cardiovascular protection after the 2025 SOUL trial showed a 14% reduction in major adverse cardiovascular events (MACE)

Obesity is a complex disease and the cause for many chronic health conditions ranging from type 2 diabetes and heart disease to several types of cancer

Researchers suggest maintaining a healthy diet and staying hydrated to keep the skin elastic and less prone to tearing

A reanalysis of the STAR*D studys patient-level data with fidelity to the original research protocol

Contraception: a special note for tirzepatide There is one contraception detail that is specific to tirzepatide (the active ingredient in Mounjaro and Zepbound) and does not apply to semaglutide